Calidi Biotherapeutics Email Format

Biotechnology ResearchCalifornia, United States11-50 Employees

Calidi Biotherapeutics is a clinical-stage biotechnology company based in San Diego, California, focused on developing oncolytic viral therapies delivered via stem cell–based platforms. Its pipeline includes lead candidate CLD-401 and the CLD-501 program targeting TROP2, with ongoing exploration of additional targets such as EGFR, EpCAM, and Nectin-4. The company operates with a relatively small to mid-sized team and participates in oncology research and development within the biotechnology sector.

Recent activities include integrating with Usetransfer to access TransferAI's Sofie platform, intended to support regulatory workflows for biopharma. Calidi has presented preclinical data at major conferences, including AACR, on its RedTail virotherapy, which can co-express immunostimulatory components in the tumor microenvironment and supports systemic delivery, with CLD-401 highlighted as a lead candidate.

Sign up for free to view info

Company overview Employee directory